Results 61 to 70 of about 4,676,099 (307)

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.

JAMA Oncology, 2022
Importance Cytokine storm due to COVID-19 can cause high morbidity and mortality and may be more common in patients with cancer treated with immunotherapy (IO) due to immune system activation.
Z. Bakouny, C. Labaki, P. Grover, J. Awosika, S. Gulati, Chih-Yuan Hsu, Saif I. Alimohamed, B. Bashir, S. Berg, M. Bilen, D. Bowles, Cecilia Castellano, A. Desai, A. Elkrief, O. Eton, L. Fecher, D. Flora, M. Galsky, M. Gatti-Mays, Alicia Gesenhues, M. Glover, D. Gopalakrishnan, Shilpa Gupta, T. Halfdanarson, B. Hayes-Lattin, M. Hendawi, E. Hsu, C. Hwang, R. Jandarov, C. Jani, Douglas B. Johnson, M. Joshi, H. Khan, Shaheer Khan, N. Knox, V. Koshkin, A. Kulkarni, D. Kwon, S. Matar, R. McKay, S. Mishra, F. Moria, A. Nizam, N. Nock, Taylor K. Nonato, J. Panasci, L. Pomerantz, A. Portuguese, D. Provenzano, M. Puc, Y. Rao, T. Rhodes, Gregory Riely, Jacob J Ripp, Andrea V. Rivera, E. Ruíz-García, A. Schmidt, A. Schoenfeld, Gary K. Schwartz, Sumit A Shah, J. Shaya, S. Subbiah, L. Tachiki, M. Tucker, Melissa Valdez-Reyes, L. Weissmann, M. Wotman, E. Wulff-Burchfield, Zhuoer Xie, Y. Yang, M. Thompson, D. Shah, J. Warner, Y. Shyr, T. Choueiri, T. Wise-Draper   +75 more
semanticscholar   +1 more source

Managing the TME to improve the efficacy of cancer therapy

Frontiers in Immunology, 2022
The tumor microenvironment (TME) influences tumor growth, metastatic spread and response to treatment. Often immunosuppression, mediated by the TME, impairs a beneficial response. The complexity of the tumor composition challenges our abilities to design
M. Bilotta, A. Antignani, D. FitzGerald
semanticscholar   +1 more source

Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use. [PDF]

, 2016
Background and aimsAll-oral interferon-free antivirals are highly effective in treating recurrent hepatitis C (HCV) infection in liver transplant (LT) recipients.
Bau, Sherona, Busuttil, Ronald W, Choi, Gina, Durazo, Francisco, El Kabany, Mohammed, Elashoff, David, Farid, Alexander, Grotts, Jonathan, Han, Steven, Jamal, Naadir, Jimenez, Melissa, Rheem, Justin, Saab, Sammy   +12 more
core   +2 more sources

Pancreas and islet cell transplantation [PDF]

, 2002
Currently, for the patient with type 1 diabetes, a definitive treatment without resorting to the use of exogenous insulin can be achieved only with pancreas or islet cell transplantation.
A.N. Balamurugan, Alexander, Allen, Amos, Barber, Barrou, Bartlett, Björk, Bonner-Weir, Brekke, Calne, Calne, Cameron, Cheung, Chow, Corry, Diem, Diem, DiLandro, Fontes, Giannoukakis, Giannoukakis, Gibson, Gliedman, Grey, Groth, Groth, Gu, Gupta, Harris, Hayek, Henry, Ilieva, Kelly, Kemp, Kendall, Kendall, Keymeulen, Kirk, Koike, Koike, Lacy, Lafferty, Lakey, Lillehei, London, Massimo Trucco, Mazariegos, Mintz, Murray, Najarian, Nghiem, Paraskevas, Petruzzo, Piehlmeier, Pipeleers-Marichal, Posselt, Prevost, Rajotte, Ramiya, Ramos, Ricordi, Rita Bottino, Robertson, Shapiro, Simeonovic, Solders, Sollinger, Sollinger, Sollinger, Soria, Ssobolew, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Stone, Stratta, Stratta, Sutherland, Suzuki, Tchervenivanov, Terasaki, Thomas E. Starzl, Tyden, Tzakis, Yasunami   +94 more
core   +1 more source

Fk506 “rescue” for resistant rejection of renal allografts under primary cyclosporine immunosuppression [PDF]

, 1994
Seventy-seven patients with ongoing acute rejection on initial CsA therapy were converted to FK506 to attempt graft salvage. Fifty-nine patients had undergone primary transplantation and 18 had been retransplanted; there were 52 cadaveric and 25 living ...
Carrieri, G, Demetris, AJ, Fung, JJ, Hakala, TR, Jordan, ML, Mc Cauley, J, Rhandhawa, P, Scantlebury, VP, Shapiro, R, Simmons, RL, Starzl, TE, Tzakis, A, Vivas, CA   +12 more
core   +1 more source

Interleukin-2 receptor antagonists for pediatric liver transplant recipients: A systematic review and meta-analysis of controlled studies [PDF]

Pediatric Transplantation, 18(8):839-850, 2014, 2014
Interleukin-2 receptor antagonists (IL-2RA) are frequently used as induction therapy in liver transplant recipients to decrease the risk of acute rejection while allowing the reduction of concomitant immunosuppression. The exact association with the use of IL-2RA however is uncertain.
arxiv   +1 more source

Fulminant Myocarditis in Patients With Autoimmune Disease That Requires Extracorporeal Membrane Oxygenation Support [PDF]

Texas Heart Institute Journal
Myocarditis is a potentially life-threatening inflammatory disease of the myocardium, often resulting from infectious and immune-mediated responses. Clinical presentation in severe cases often results in a devastating illness requiring extracorporeal ...
Filip Depta, MD, PhD, Ingrid Olejárová, MD, PhD, Dušan Rybár, MD, PhD, Pavol Murín, MD, PhD, Marián Švajdler, MD, PhD, Tomáš Grendel, MD, PhD   +5 more
doaj   +1 more source

Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma. [PDF]

PLoS ONE, 2013
Immunosuppression therapy following liver transplantation often includes steroids. However, extended corticosteroid therapy is associated with numerous complications.
Tonghai Xing, Li Huang, Zhenhai Yu, Lin Zhong, Shuyun Wang, Zhihai Peng   +5 more
doaj   +1 more source

Cytokine‐ and chemokine‐induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy

Cancer Communications, 2022
Colorectal cancer (CRC) is a predominant life‐threatening cancer, with liver and peritoneal metastases as the primary causes of death. Intestinal inflammation, a known CRC risk factor, nurtures a local inflammatory environment enriched with tumor cells ...
Ajaz A. Bhat, Sabah Nisar, Mayank Singh, Bazella Ashraf, Tariq Ahmad Masoodi, C. P. Prasad, Atul Sharma, Selma Maacha, Thasni Karedath, Sheema Hashem, S. Yasin, P. Bagga, Ravinder Reddy, M. Frennaux, S. Uddin, P. Dhawan, Mohammad Haris, M. Macha   +17 more
semanticscholar   +1 more source

FIRST EXPERIENCE OF APPLICATION OF ASSIST CIRCULATION DEVICE USING BIVENTRICULAR TYPE «EXCOR»

Вестник хирургии имени И.И. Грекова, 2018
The frequency of use of assist blood device as the «bridge» to the heart transplantation increased in last years. An assessment of results of first 7 implantations of assist circulation device using biventricular type «Excor» was made.
M. L. Gordeev, M. A. Karpenko, G. V. Nikolaev, A. S. Gnevashev, E. Ya. Malaya, A. V. Naimushin, V. E. Rubinchik, I. V. Sukhova, L. B. Mitrofanova, M. Yu. Somin, Yu. V. Sazonova, S. S. Stepanov, P. A. Fedotov   +12 more
doaj   +1 more source